analyzing predictors of response to neoadjuvant chemotherapy in breast cancer
Published 5 years ago • 467 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
30:40
prediction of response to anthracycline-based chemotherapy in early breast cancer
-
1:47
evaluating the role of neoadjuvant endocrine therapy in breast cancer
-
1:29
the predictive value of treatment response after neoadjuvant therapy
-
0:55
neoadjuvant treatment approach for her2 positive breast cancer
-
1:13
predictive markers of response to durvalumab w/nab-paclitaxel doxorubicin/cyclophosphamide in tnbc
-
4:37
shades of pink foundation supports breast cancer patients in southeast michigan
-
17:37
elisabeth morris: response to neoadjuvant chemotherapy
-
1:40
predicting pathological complete response in breast cancer
-
16:58
assessing immune biomarkers of response to anthracyclines in breast cancer
-
4:12
radiographic, biochemical or pathologic response to neoadjuvant chemotherapy in resected...
-
1:47
defining factors that can predict neoadjuvant chemotherapy response in breast cancer
-
2:28
improving breast cancer treatment: incorporating immune predictors for better outcomes
-
1:20
dr. mcquade on age as a predictor of response to neoadjuvant immunotherapy in melanoma
-
3:01
alternate: neoadjuvant chemotherapy in er her2- breast cancer
-
48:39
joel parker - prediction of enzalutamide sensitivity in triple negative breast cancer
-
1:53
dr. harry bear on translating pathological complete response to os benefits
-
1:10
dr. tereffe on treatment after neoadjuvant chemotherapy in breast cancer